NATiAS
Latest round
- Series B
Last raised
- Mar 2022
Total raised
- $2.9M
Investors
- 3
About NATiAS
Based in Japan, NATiAS Inc.NATiAS Inc. was founded in 2015 and is headquartered in Kobe-shi, Japan.,Ltd.NATiAS Inc. specializes in the contract manufacturing of nucleic acids, focusing on active pharmaceutical ingredients (APIs) and diagnostic primers. Their core product, Blockmer®, uses proprietary technology that significantly reduces the nucleic acid synthesis process duration compared to traditional methods. The company serves a range of clients, including pharmaceutical companies, biotechnology firms, and research institutions involved in genomic research and therapeutic developments.NATiAS Inc. generates revenue through B2B transactions with pharmaceutical and biotechnology companies that require nucleic acid manufacturing solutions. Their business model incorporates direct sales agreements for their specialized products, including Blockmer® and nucleic acid APIs, which meet specific client requirements. The company offers customized contracts to ensure clients receive tailored solutions for their development timelines and regulatory needs. Emphasizing quality and efficiency, NATiAS positions its flagship products at a premium value, which reflects the advanced technology and expertise involved in their production. These actions are expected to enhance their product offerings and market reach. Additionally, NATiAS is planning to expand into new markets, specifically targeting additional regions in North America and Europe within the next 18 months, leveraging their innovative technologies to meet growing demands.
Who invested in NATiAS
3 investors across 1 round
See all investors in NATiAS
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Mar 9, 2022
Amount
$2.9M
Investors
Questions about NATiAS
Who invested in NATiAS?
NATiAS has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has NATiAS raised?
NATiAS has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did NATiAS last raise money?
NATiAS's most recent round on record is a Series B, in Mar 2022.
What does NATiAS do?
NATiAS is a biotechnology company.
Where is NATiAS headquartered?
NATiAS is headquartered in Kobe-shi, Japan.
Which VCs invest in companies like NATiAS?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at NATiAS's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like NATiAS? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.